208 related articles for article (PubMed ID: 23300683)
1. Establishment, characterization and chemosensitivity of three mismatch repair deficient cell lines from sporadic and inherited colorectal carcinomas.
Maletzki C; Stier S; Gruenert U; Gock M; Ostwald C; Prall F; Linnebacher M
PLoS One; 2012; 7(12):e52485. PubMed ID: 23300683
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
[TBL] [Abstract][Full Text] [Related]
3. Functional Characterization and Drug Response of Freshly Established Patient-Derived Tumor Models with CpG Island Methylator Phenotype.
Maletzki C; Huehns M; Knapp P; Waukosin N; Klar E; Prall F; Linnebacher M
PLoS One; 2015; 10(11):e0143194. PubMed ID: 26618628
[TBL] [Abstract][Full Text] [Related]
4. Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines.
Gock M; Mullins CS; Bergner C; Prall F; Ramer R; Göder A; Krämer OH; Lange F; Krause BJ; Klar E; Linnebacher M
World J Gastroenterol; 2018 Nov; 24(43):4880-4892. PubMed ID: 30487698
[TBL] [Abstract][Full Text] [Related]
5. [Mismatch repair (MMR) efficiency and MSH2 gene mutation in human colorectal carcinoma cell line COLO320HSR].
Tronov VA; Kramarenko II; Maĭorova EN; Zakharov SF
Genetika; 2007 Apr; 43(4):537-44. PubMed ID: 17555131
[TBL] [Abstract][Full Text] [Related]
6. Mismatch repair deficient colorectal cancer in the era of personalized treatment.
Hewish M; Lord CJ; Martin SA; Cunningham D; Ashworth A
Nat Rev Clin Oncol; 2010 Apr; 7(4):197-208. PubMed ID: 20177404
[TBL] [Abstract][Full Text] [Related]
7. Clinical Impact of Mismatch Repair Protein Testing on Outcome of Early Staged Colorectal Carcinomas.
Gandhi JS; Goswami M; Sharma A; Tanwar P; Gupta G; Gupta N; Pasricha S; Mehta A; Singh S; Agarwal M; Gupta N
J Gastrointest Cancer; 2018 Dec; 49(4):406-414. PubMed ID: 28585041
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications.
Zaanan A; Meunier K; Sangar F; Fléjou JF; Praz F
Cell Oncol (Dordr); 2011 Jun; 34(3):155-76. PubMed ID: 21484480
[TBL] [Abstract][Full Text] [Related]
9. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.
Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J
PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813
[TBL] [Abstract][Full Text] [Related]
10. Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma.
Kaur G; Masoud A; Raihan N; Radzi M; Khamizar W; Kam LS
Indian J Med Res; 2011 Aug; 134(2):186-92. PubMed ID: 21911971
[TBL] [Abstract][Full Text] [Related]
11. Cell-free DNA blood levels in colorectal cancer patients do not correlate with mismatch repair-proficiency.
Lazarev I; Leibovitch L; Czeiger D; Sion-Vardi N; Geffen DB; Douvdevani A; Ariad S
In Vivo; 2014; 28(3):349-54. PubMed ID: 24815837
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
13. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
14. Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance.
Scarpa M; Ruffolo C; Canal F; Scarpa M; Basato S; Erroi F; Fiorot A; Dall'Agnese L; Pozza A; Porzionato A; Castagliuolo I; Dei Tos AP; Bassi N; Castoro C
Oncotarget; 2015 Dec; 6(41):43472-82. PubMed ID: 26496037
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
[TBL] [Abstract][Full Text] [Related]
16. Functional mismatch repair and inactive p53 drive sensitization of colorectal cancer cells to irinotecan via the IAP antagonist BV6.
Tomicic MT; Steigerwald C; Rasenberger B; Brozovic A; Christmann M
Arch Toxicol; 2019 Aug; 93(8):2265-2277. PubMed ID: 31289894
[TBL] [Abstract][Full Text] [Related]
17. Morphological, immunophenotypical and molecular features of hypermutation in colorectal carcinomas with mutations in DNA polymerase ε (POLE).
Forgó E; Gomez AJ; Steiner D; Zehnder J; Longacre TA
Histopathology; 2020 Feb; 76(3):366-374. PubMed ID: 31479159
[TBL] [Abstract][Full Text] [Related]
18. Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency.
Yang JL; Qu XJ; Yu Y; Kohn EC; Friedlander ML
Int J Cancer; 2008 Jul; 123(2):258-263. PubMed ID: 18464258
[TBL] [Abstract][Full Text] [Related]
19. Relevance, pathogenesis, and testing algorithm for mismatch repair-defective colorectal carcinomas: a report of the association for molecular pathology.
Funkhouser WK; Lubin IM; Monzon FA; Zehnbauer BA; Evans JP; Ogino S; Nowak JA
J Mol Diagn; 2012; 14(2):91-103. PubMed ID: 22260991
[TBL] [Abstract][Full Text] [Related]
20. Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer.
Ramchander NC; Ryan NAJ; Walker TDJ; Harries L; Bolton J; Bosse T; Evans DG; Crosbie EJ
Front Immunol; 2019; 10():3023. PubMed ID: 31998307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
